{{Rsnum
|rsid=2295080
|Gene=MTOR
|Chromosome=1
|position=11262571
|Orientation=plus
|GMAF=0.4141
|Gene_s=MTOR
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 6.2 | 47.7 | 46.2
| HCB | 0.0 | 0.0 | 0.0
| JPT | 0.0 | 0.0 | 0.0
| YRI | 0.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23209702
|Title=A Functional Variant in the MTOR Promoter Modulates Its Expression and Is Associated with Renal Cell Cancer Risk
|OA=1
}}

{{PMID Auto
|PMID=22815832
|Title=Genetic variations in a PTEN/AKT/mTOR axis and prostate cancer risk in a Chinese population
|OA=1
}}

{{PMID Auto
|PMID=19164214
|Title=Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy.
|OA=1
}}

{{PMID Auto
|PMID=21973240
|Title=Association of genetic variations in mTOR with risk of childhood acute lymphoblastic leukemia in a Chinese population.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}